These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20429318)

  • 21. Patient preference for eletriptan 80 mg versus subcutaneous sumatriptan 6 mg: results of a crossover study in patients who have recently used subcutaneous sumatriptan.
    Schoenen J; Pascual J; Rasmussen S; Sun W; Sikes C; Hettiarachchi J
    Eur J Neurol; 2005 Feb; 12(2):108-17. PubMed ID: 15679698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and efficacy of eletriptan in the treatment of acute migraine.
    Takiya L; Piccininni LC; Kamath V
    Pharmacotherapy; 2006 Jan; 26(1):115-28. PubMed ID: 16506353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine.
    Chen LC; Ashcroft DM
    Headache; 2008 Feb; 48(2):236-47. PubMed ID: 18179569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Zolmitriptan as fast-melt tablet in the acute treatment of patients with migraine attacks: the ZORO study].
    Stöckli HR; Sword A
    Praxis (Bern 1994); 2003 Feb; 92(9):379-89. PubMed ID: 12674591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eletriptan.
    Sandrini G; Perrotta A; Tassorelli C; Nappi G
    Expert Opin Drug Metab Toxicol; 2009 Dec; 5(12):1587-98. PubMed ID: 19929447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of eletriptan in triptan-naïve patients: results of a combined analysis.
    Martin VT; Valade D; Almas M; Hettiarachchi J; Sikes C; Albert KS; Parsons B
    Headache; 2007 Feb; 47(2):181-8. PubMed ID: 17300357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perimenstrual eletriptan prevents menstrual migraine: an open-label study.
    Marcus DA; Bernstein CD; Sullivan EA; Rudy TE
    Headache; 2010 Apr; 50(4):551-62. PubMed ID: 20236337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacology and efficacy of eletriptan for the treatment of migraine attacks.
    Diener HC; McHarg A
    Int J Clin Pract; 2000 Dec; 54(10):670-4. PubMed ID: 11221281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preference for rizatriptan 10-mg wafer vs. eletriptan 40-mg tablet for acute treatment of migraine.
    Láinez MJ; Evers S; Kinge E; Allais G; Allen C; Rao NA; Massaad R; Lis K
    Cephalalgia; 2006 Mar; 26(3):246-56. PubMed ID: 16472330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple attack study on the available triptans in Italy versus placebo.
    Vollono C; Capuano A; Mei D; Ferraro D; Pierguidi L; Evangelista M; Di Trapani G
    Eur J Neurol; 2005 Jul; 12(7):557-63. PubMed ID: 15958097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of eletriptan in reducing time loss caused by migraine attacks.
    Wells NE; Steiner TJ
    Pharmacoeconomics; 2000 Dec; 18(6):557-66. PubMed ID: 11227394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of efficacy, tolerability, and treatment satisfaction with almotriptan in 3 consecutive migraine attacks. The migraine--satisfaction with treatment: reality with Almogran study.
    Massiou H; Pradalier A; Donnet A; Lanteri-Minet M; Allaf B
    Eur Neurol; 2006; 55(4):198-203. PubMed ID: 16772716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative efficacy of triptans for the abortive treatment of migraine: a multiple treatment comparison meta-analysis.
    Thorlund K; Mills EJ; Wu P; Ramos E; Chatterjee A; Druyts E; Goadsby PJ
    Cephalalgia; 2014 Apr; 34(4):258-67. PubMed ID: 24108308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Migraine treatment strategies: the global Migraine And Zolmitriptan Evaluation (MAZE) survey--phase IV.
    MacGregor EA; Brandes J; Gendolla A; Giammarco R
    Curr Med Res Opin; 2004 Nov; 20(11):1777-83. PubMed ID: 15537478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eletriptan: a review and new perspectives.
    Sandrini G; Perrotta A; Nappi G
    Expert Rev Neurother; 2006 Oct; 6(10):1413-21. PubMed ID: 17078782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Migraine Intervention Score - a tool to improve efficacy of triptans in acute migraine therapy: the ALADIN study.
    Göbel H; Heinze A
    Int J Clin Pract; 2011 Aug; 65(8):879-86. PubMed ID: 21762313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triptans for migraine therapy: a comparison based on number needed to treat and doses needed to treat.
    Mullins CD; Weis KA; Perfetto EM; Subedi PR; Healey PJ
    J Manag Care Pharm; 2005 Jun; 11(5):394-402. PubMed ID: 15934798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders.
    Seeburger JL; Taylor FR; Friedman D; Newman L; Ge Y; Zhang Y; Hustad CM; Lasorda J; Fan X; Hewitt D; Ho T; Connor KM
    Cephalalgia; 2011 May; 31(7):786-96. PubMed ID: 21078681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tolerability and safety of eletriptan in the treatment of migraine: a comprehensive review.
    Mathew NT; Hettiarachchi J; Alderman J
    Headache; 2003 Oct; 43(9):962-74. PubMed ID: 14511273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eletriptan treatment of migraine in patients switching from barbiturate-containing analgesics: results from a multiple-attack study.
    Martin VT; Loder E; Taylor K; Almas M; Hilliard B
    Cephalalgia; 2005 Sep; 25(9):726-34. PubMed ID: 16109055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.